Delivery Order SPE2DB22D3019-SPE2DB25FK3YV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Levothyroxine 200 mcg tablets in quantities of 1,000 units, with a ceiling value of $13,837.62. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is scheduled for ultimate completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,023 to Amerisourcebergen Drug Corporation to supply 4561542223 levothyroxine 75 mcg capsules. Amerisourcebergen will deliver 30 capsules under the order, which is being performed in Conshohocken, Pennsylvania through July 20, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for levothyroxine supports the Defense Logistics Agency's mission...
- The Defense Logistics Agency awarded a delivery order valued at $348.21 to Amerisourcebergen Drug Corp for the supply of 4561783733 levothyroxine 25 mcg capsules. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 30 capsules to a location in Conshohocken, Pennsylvania, with performance required between August 11-14, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for levothyroxine supports the Agency's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,051.66 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 137 mcg tablets (100-count units) with an ultimate completion date of July 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and was awarded on July 21, 2025. The contractor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $536 to Amerisourcebergen Drug Corporation for the supply of 50 microgram levothyroxine capsules. As the prime contractor, Amerisourcebergen will deliver 30 capsules to an address in Conshohocken, Pennsylvania under a one day period of performance from July 19th to July 20th, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Levothyroxine Sodium, a thyroid hormone replacement medication. This firm fixed-price delivery order, valued at $9,454.63, is scheduled for completion by October 3, 2025, with fulfillment based at the contractor's Conshohocken, Pennsylvania facility. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Levothyroxine 25 MCG tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $1,006.96, represents a non-competitive, non-set-aside award and will be completed by September 10, 2025. The place of performance is located at the company's corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 30, 2025, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $1,723.68 with an ultimate completion date of September 2, 2025, represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Levothyroxine 100 MCG vials under a firm fixed-price contract with a ceiling value of $4,231.47. This is a non-set-aside competitive award with an ultimate completion date of September 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Levothyroxine 25 mcg capsules. The contract has a ceiling value of $1,230.19 and is set to run through August 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK3YVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,224.85 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 75 MCG Capsule in quantities of 30 units. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed price pricing and does not include a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same city. This delivery order represents a child contract executed under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying medications and medical commodities to support military healthcare systems and other government agencies through the Defense Logistics Agency's Medical Supply Chain. The award reflects the contractor's demonstrated capability to meet federal procurement requirements in open competition, with delivery orders spanning a wide range of therapeutic domains from specialty medications to generic drugs. The levothyroxine delivery under this order supports the company's broader mission of providing essential pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/22/25 |